 |
Trials |
A phase 1B study to evaluate safety anf clinical activity of pembrolozumab (MK-3475) in combination with chemotherapy as neoadjuvant treatment for trible negative breast cancerCancer type: Breast cancer Phase: I Principal Investigator: Mattson Johanna Country: FI Keywords: Finland, Helsinki Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02622074?term=2015-002405-11&rank=1 |